CVS Health reaffirms its estimated full-year 2022 adjusted earnings per share guidance range and expects to exceed its revenue guidance range. It also reaffirms its projected full-year 2023 adjusted EPS guidance range and provides updates on its Medicare Advantage membership growth and individual public health insurance exchange footprint expansion.